Mirae Asset Global Investments
FENC icon

Mirae Asset Global Investments’s Fennec Pharmaceuticals FENC Stock Holding History

Mirae Asset Global Investments’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,398
Closed -$117K – 2508
2023
Q4 		$117K Hold
10,398
– – ﹤0.01% 2434
2023
Q3 		$78.1K Hold
10,398
– – ﹤0.01% 2507
2023
Q2 		$91.8K Buy
+10,398
New +$86.5K ﹤0.01% 2536

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return

Mirae Asset Global Investments's FENC Position: Q1 2024 in Review

Mirae Asset Global Investments sold out of Fennec Pharmaceuticals (FENC) in Q1 2024, closing a stake of 10,398 shares — an estimated $117K sold.

Mirae Asset Global Investments first reported a position in FENC in Q2 2023 and held it in 3 quarters. The position peaked at $117K in Q4 2023. 65 funds tracked by Wall St. Rank hold FENC as of Q1 2024.

  • Mirae Asset Global Investments reported no remaining Fennec Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 10,398 Fennec Pharmaceuticals shares in Q1 2024, an estimated $117K.
  • Mirae Asset Global Investments first reported a position in Fennec Pharmaceuticals in Q2 2023 and held it in 3 quarters.
  • Mirae Asset Global Investments's Fennec Pharmaceuticals position peaked at $117K in Q4 2023.
  • 65 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2024.

Based on Mirae Asset Global Investments's 13F filing for Q1 2024, filed 1 May 2024.